San Francisco, CA, United States of America

Moses Lee

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Kabam, Inc., Research Corporation Technologies, Inc.. Active years: 1993-2024.

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Greenville, SC (US) (1993)
San Francisco, CA (US) (2014 - 2021)
Vancouver, WA (US) (2024)

Company Filing History:

Research Corporation Technologies, Inc.

patents

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12126500 - Dynamically providing system communications tailored to individual users responsive to trigger events in virtual spaces (2024-10-22),

2. 11964943 - 3,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of Stat3 pathway activity and uses thereof (2024-04-23),

3. 10992545 - Dynamically providing system communications in a virtual space tailored to individual users responsive to specific user actions and individual current states (2021-04-27),

4. 10171385 - Dynamically providing system communications in a virtual space tailored to individual users responsive to specific user actions and individual current states (2019-01-01),

5. 8880629 - Dynamically providing system communications tailored to individual users responsive to trigger events in virtual spaces (2014-11-04),

6. 5273991 - Imidazole-containing compositions and methods of use thereof analogs of (1993-12-28),

Title: The Innovative Mind of Moses Lee

Introduction

Moses Lee is a prominent inventor based in San Francisco, CA. He holds a total of 6 patents that showcase his contributions to technology and pharmaceuticals. His work reflects a deep understanding of user interaction in virtual spaces and the development of therapeutic agents.

Latest Patents

One of Moses Lee's latest patents is titled "Dynamically providing system communications tailored to individual users responsive to trigger events in virtual spaces." This invention focuses on delivering personalized system communications based on user activities in virtual environments. It includes various forms of communication, such as advertisements and informative messages, tailored to enhance user experience based on their interactions.

Another significant patent is "3,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of Stat3 pathway activity and uses thereof." This invention involves compounds that are useful in treating disorders like cancer and autoimmune diseases. The compounds can inhibit the Stat3 pathway, which is often associated with various cancers, and can be combined with other therapeutic agents for enhanced efficacy.

Career Highlights

Moses Lee has worked with notable companies such as Kabam, Inc. and Research Corporation Technologies, Inc. His experience in these organizations has contributed to his innovative approach in both gaming technology and pharmaceutical development.

Collaborations

Moses has collaborated with talented individuals like Clive Henrick and Benjamin Sai Yee. Their combined expertise has likely fostered a creative environment that encourages groundbreaking innovations.

Conclusion

Moses Lee's inventive spirit and dedication to improving user experiences and health outcomes through his patents make him a noteworthy figure in the fields of technology and pharmaceuticals. His contributions continue to influence various industries and inspire future innovations.